ENGN enGene Bio Year-over-year net earnings per share growth for the last 12 months

enGene - graphic logo of issuer ENGN

enGene Holdings Inc. (ENGN) is developing a unique non-viral DNA delivery system, ensuring patent priority and premium product pricing. This quarterly EPS chart visualizes the financial results of these operations, where the 17.90 mark serves as a key metric. The business relies on external contractors for vector production, while upcoming bladder cancer therapy trials will act as the primary growth drivers.

engene.com (ENGN) Year-over-year earnings per share growth for the last 12 months: for the period 02/21/2024 - 11/18/2026

Analytical breakdowns for enGene Holdings Inc.

- market value and analyst target forecast:
Summary company analysis:enGene Holdings Inc - ENGN
Flagship merchandise of enGene Holdings Inc.

enGene Holdings Inc. (ENGN) specializes in developing patent-protected immune drugs that require colossal R&D expenditures. By analyzing the quarterly EPS growth efficiency rate, one can assess the impact of these expenses on net income. This metric measures the dynamics of earnings per share, revealing the pressure of costs on the operating margin. Negative values here reflect investments in FDA clinical trials, which allows for the determination of the asset's long-term sustainability.

Competitors of enGene Holdings Inc.

argenx BVBA (ARGX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months BioNTech SE|Year-over-year net earnings per share growth for the last 12 months ABVX|Quarterly EPS earnings growth admabiologics.com|Year-over-year earnings per share growth for the last twelve months Protagonist Therapeutics Inc (PTGX)|Immunovant - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth KNSA (kiniksa.com)|Grifols Group (GRFS) - Earnings per share growth in annualized terms for the last twelve months|Adaptive Biotechnologies Inc. - Quarterly EPS earnings growth|Celldex Therapeutics (CLDX) - Year-over-year net earnings per share growth for the last 12 months|AUPH (auriniapharma.com) - Year-over-year net earnings per share growth for the last 12 months|BCRX - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Vera Pharma|Quarterly EPS earnings growth Dianthus Corp|Year-over-year earnings per share growth for the last twelve months Pharvaris N.V. (PHVS)|ABCL - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Tourmaline Bio Inc TRML|Year-over-year net earnings per share change for the last twelve months Precigen (PGEN)|Pharming Corp - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months NKTR (Nektar Therapeutics)|upstreambio.com (UPB) - Year-over-year earnings per share growth for the last twelve months|ZBIO (Zenas Biopharma Inc) - Year-over-year earnings per share growth for the last twelve months|IMNM (Immunome Bio) - Quarterly EPS earnings growth|GOSS: Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months KALV (KalVista Pharmaceuticals Inc)|SEPN (Septerna Corp) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth PVLA (Pieris Corp)|SVRA - Year-over-year net earnings per share growth for the last 12 months|RIGL - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months ANAB (AnaptysBio)|ATXS: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months RAPT Therapeutics, Inc. (RAPT)|Year-over-year earnings per share growth for the last twelve months aerovatetx.com|Quarterly EPS earnings growth aclaristx.com|Year-over-year earnings per share growth for the last twelve months Kyverna Therapeutics (KYTX)|Year-over-year net earnings per share change for the last twelve months Tiziana Life Sciences Ltd|Quarterly EPS earnings growth CABA (Cabaletta Bio Inc)|VTYX: Year-over-year earnings per share growth for the last 12 months|Theratechnologies, Inc. - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Avalo Therapeutics, Inc AVTX|ELDN (Eledon Pharmaceuticals) - Year-over-year net earnings per share growth for the last 12 months|Agenus Inc. - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Climb Bio|Quarterly EPS earnings growth Zura Bio Ltd|Year-over-year net earnings per share growth for the last 12 months ATYR (aTyr Pharma Inc)|Year-over-year net earnings per share change for the last twelve months Adagene Inc|Year-over-year earnings per share growth for the last twelve months ImageneBio Inc IMA|Year-over-year earnings per share growth rate for the last twelve months STTK (shattucklabs.com)|EQ: Year-over-year net earnings per share growth for the last 12 months|CNTB: Year-over-year earnings per share growth for the last twelve months|IMUX: Quarterly EPS earnings growth|Atara Biotherapeutics (ATRA) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months IFRX|Quarterly EPS earnings growth X4 Pharmaceuticals Inc.|Year-over-year earnings per share growth for the last twelve months Adicet Bio Inc. (ACET)|Year-over-year net earnings per share growth for the last 12 months Celularity CELU|Quarterly EPS earnings growth INMB (INmune Bio Corporation)|Year-over-year net earnings per share change for the last twelve months Barinthus Biotherapeutics (BRNS)|KZR - Year-over-year earnings per share growth for the last twelve months|SABS - Quarterly EPS earnings growth|Akari Therapeutics, Plc (AKTX) - Year-over-year earnings per share growth for the last twelve months|Enlivex Therapeutics, Ltd. (ENLV) - Quarterly EPS earnings growth|QTTB (Q32 Bio Inc) - Quarterly EPS earnings growth|geovax.com (GOVX) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months EDSA (Edesa Biotech)|Year-over-year net earnings per share change for the last twelve months iBio Inc|Quarterly EPS earnings growth CARM (Carisma Therapeutics Inc)|Year-over-year earnings per one share growth for the last 12 months XTLB|BOLT: Year-over-year net earnings per share growth for the last 12 months|HCW Biologics (HCWB) - Year-over-year net earnings per share growth for the last 12 months|Aptevo (APVO) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months AIM ImmunoTech|Year-over-year net earnings per share growth for the last 12 months ADTX|GRI Bio Corporation (GRI) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months XRTX (XORTX Therapeutics Inc.)|Vyome Holdings Inc - Year-over-year earnings per share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Revelation Biosciences Inc REVB|INDP - Year-over-year net earnings per share growth for the last 12 months|SCNI: Year-over-year net earnings per share growth for the last 12 months|CALI: Year-over-year earnings per share growth for the last twelve months|AFMD: Quarterly EPS earnings growth|Allakos Inc - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months HOOKIPA Pharma, Inc.|IGM Biosciences, Inc. (IGMS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months iteostherapeutics.com (ITOS)|OCEA - Earnings per share growth in annualized terms for the last twelve months|TC BioPharm (Holdings) PLC - Year-over-year net earnings per share growth for the last 12 months|THRD: Year-over-year earnings per share growth for the last 12 months